• DRD4 Drives Chemo-Resistance via Akt/β-Catenin in Liver Canc

  2026-06-14

  This study uncovers a pivotal role for DRD4 in promoting chemo-resistance and cancer stem cell-like phenotypes in hepatocellular carcinoma by activating the PI3K/Akt/β-catenin signaling axis. The findings highlight DRD4 as a mechanistically distinct target for overcoming multidrug resistance and improving therapy outcomes in liver cancer.

• Doxycycline Hyclate: Matrix Metalloproteinases Inhibitor in

  2026-06-13

  Doxycycline hyclate enables precise inhibition of MMP-2 and MMP-9, preserving blood-brain barrier integrity in neurotoxic and inflammatory models. Its robust solubility and validated in vivo efficacy make it a first-line tool for dissecting neurovascular mechanisms and evaluating protective strategies.

• Nullscript: Advanced HDAC Inhibition for Translational Resea

  2026-06-12

  Explore Nullscript, a distinctive histone deacetylase inhibitor, in the context of translational research. This article delves deeper into its mechanistic nuances, unique inactivity in transcriptional facilitation, and the implications for cardiac and neurodegenerative disease assays.

• Cell Cycle Assay Kit K2263: Precision in Epigenetic and Apop

  2026-06-12

  Unlock advanced cell cycle phases G0/G1, S, and G2/M analysis with the Cell Cycle Assay Kit. This article reveals how K2263 empowers nuanced epigenetic drug studies and apoptosis detection, bridging scientific insight with real-world research needs.

• Foretinib (GSK1363089): Workflow Optimization in Cancer Mode

  2026-06-11

  Foretinib (GSK1363089) empowers researchers to dissect tumor cell growth and metastasis with robust, quantifiable inhibition across a spectrum of cancer cell lines. This article details data-driven workflows, protocol enhancements, and troubleshooting strategies that maximize the translational impact of this advanced multikinase inhibitor.

• CFTRinh-172 in Epithelial Research: Precision CFTR Inhibitio

  2026-06-11

  CFTRinh-172 is a highly selective CFTR inhibitor that enables rapid, reproducible assays of chloride channel activity in epithelial models. This guide translates the latest advances in CFTR trafficking and SHC-1 pathway modulation into actionable protocols and troubleshooting insights, empowering cystic fibrosis and secretory diarrhea research with superior workflow control.

• DAMGO in Advanced Opioid Receptor Signaling: From Precision

  2026-06-10

  Explore the unique advantages of DAMGO as a selective µ-opioid receptor agonist in opioid receptor signaling research and chronic pain models. This article delivers an in-depth analysis of DAMGO’s mechanistic, experimental, and translational significance, revealing new insights beyond current literature.

• MMP-2/9-Mediated BBB Disruption Drives Arsenic Neurotoxicity

  2026-06-10

  A recent study demonstrates that chronic sodium arsenite exposure impairs learning and memory in male mice through matrix metalloproteinase-2 and -9 (MMP-2/9)-mediated blood-brain barrier (BBB) disruption and neuronal apoptosis. Doxycycline hyclate, a matrix metalloproteinases inhibitor, preserved BBB integrity and reduced cognitive deficits, offering mechanistic insight and a translational research tool for neurotoxicology and neurovascular studies.

• SM-102 Enables Efficient mRNA Delivery: Protocols and Pitfal

  2026-06-09

  SM-102 is a high-purity synthetic lipid powering the next generation of mRNA delivery, as demonstrated in tumor suppressor replacement therapy for bladder cancer. This article delivers bench-ready workflows, advanced troubleshooting, and a practical translation of the latest peer-reviewed findings, helping researchers optimize lipid nanoparticle formulations with confidence.

• 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine:

  2026-06-09

  Explore how 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine, a potent α2-adrenergic receptor agonist, enables advanced immune rejection modulation in post-surgery osteosarcoma research. This article reveals mechanistic innovations and assay guidance unavailable in prior content.

• Artesunate in Cancer Research: Optimized Workflows & Trouble

  2026-06-08

  Artesunate, a potent artemisinin derivative, enables precision targeting of cancer cell death pathways via AKT/mTOR inhibition and ferroptosis induction. This article offers actionable protocol enhancements, troubleshooting guidance, and comparative insights for maximizing Artesunate's impact in advanced cancer models.

• ZCL278 (SKU A8300): Reliable Cdc42 Inhibition for Cell Assay

  2026-06-08

  Discover how ZCL278 (SKU A8300), a selective Cdc42 inhibitor, addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays. This article provides scenario-driven guidance for optimizing workflows, interpreting data, and selecting high-quality reagents with proven performance. Leverage the validated protocols and peer-reviewed evidence supporting ZCL278 for reproducible, high-impact results.

• Mitoxantrone Targets ERα DBD-LBD Interface to Overcome Resis

  2026-06-07

  Wang et al. reveal mitoxantrone’s unique mechanism in disrupting estrogen receptor α (ERα) function by binding a novel DBD-LBD allosteric interface, leading to proteasomal degradation of both wild-type and therapy-resistant ERα mutants. This approach offers a promising alternative for circumventing resistance in luminal breast cancer, expanding the functional landscape for DNA topoisomerase II inhibitors.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: New E

  2026-06-06

  Chen et al. (2021) demonstrate that moesin (MSN) is elevated in septic patients and animal models, correlating with the severity of endothelial injury and inflammatory response. Their findings support MSN as a novel biomarker for assessing vascular damage in sepsis, offering mechanistic insight into the Rock1/MLC and NF-κB pathways.

• Toxicity of Sulfamonomethoxine to Aquatic Organisms: New Ins

  2026-06-05

  This study provides a quantitative assessment of the acute and chronic toxicity of Sulfamonomethoxine (SMM) to key aquatic species, highlighting differential sensitivity among trophic levels. The findings offer critical guidance for environmental risk evaluation of veterinary antibiotic use in aquaculture.

456 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page